Effects of sodium-glucose cotransporter-2 inhibitors on chronic kidney disease progression: a multi-state survival model
SGLT2i may delay the decline in renal function and slow CKD progression compared to standard care without SGLT2i.
Authors
- Amarit Tansawet (ORCID: https://orcid.org/0000-0002-2040-7970)
- Panu Looareesuwan (ORCID: https://orcid.org/0000-0001-8179-9149)
- Oraluck Pattanaprateep (ORCID: https://orcid.org/0000-0001-9570-2635)
- Sarinya Boongird (ORCID: https://orcid.org/0000-0002-3194-1511)
- John Attia (ORCID: https://orcid.org/0000-0001-9800-1308)
- Gareth J. McKay (ORCID: https://orcid.org/0000-0001-8197-6280)
- Ammarin Thakkinstian (ORCID: https://orcid.org/0000-0001-9991-386X)
- Htun Teza (ORCID: https://orcid.org/0000-0002-1076-9513)
Institutions
- Queen's University Belfast (GB)
- Mahidol University (TH)
- Navamindradhiraj University (TH)
- Vajira Hospital (TH)
- Hunter Medical Research Institute (AU)
- Ramathibodi Hospital (TH)
Publication Details
- Journal
- Diabetology & Metabolic Syndrome
- Published
- 2024-11-23
- DOI
- https://doi.org/10.1186/s13098-024-01522-6
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Mahidol University
- National Research Council of Thailand
- Medical Research Council